In line with our previous observations (Poulogiannis et al., 2010), PARK2 has many of the properties of a haploinsufficient tumor suppressor in that loss of a single Park2 allele exacerbates tumorigenesis without requiring complete inactivation of the remaining allele. The gene discussed is PRKN; the disease is neoplasm.